化学生物学与药物设计：两个多学科领域的三维、动态及机制特性。 - Suppr

Suppr

超能文献

Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.

作者信息

Sawyer Tomi K

机构信息

Chemical Biology & Drug Design, Drug Discovery, ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA.

出版信息

Chem Biol Drug Des. 2006 Mar;67(3):196-200. doi: 10.1111/j.1747-0285.2006.00371.x.

DOI:10.1111/j.1747-0285.2006.00371.x

PMID:16611212

Abstract

摘要

相似文献

Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.

Chem Biol Drug Des. 2006 Mar;67(3):196-200. doi: 10.1111/j.1747-0285.2006.00371.x.

The impact of systems approaches on biological problems in drug discovery.

Nat Biotechnol. 2004 Oct;22(10):1215-7. doi: 10.1038/nbt1004-1215.

Molecular targets and cancer therapeutics.

Drug Discov Today. 2004 Dec 15;9(24):1042-4. doi: 10.1016/S1359-6446(04)03287-8.

Can cell systems biology rescue drug discovery?

Nat Rev Drug Discov. 2005 Jun;4(6):461-7. doi: 10.1038/nrd1754.

Seeing is believing--visualizing drug delivery in vitro and in vivo.

Adv Drug Deliv Rev. 2005 Jun 15;57(8):1085-6. doi: 10.1016/j.addr.2005.01.019.

Ligand-based vascular targeting of disease.

ChemMedChem. 2007 Jan;2(1):22-40. doi: 10.1002/cmdc.200600181.

Value of novelty?

Nat Rev Drug Discov. 2002 Aug;1(8):571-2. doi: 10.1038/nrd884.

The journal of pharmacy and pharmacology 2008.

J Pharm Pharmacol. 2009 Jan;61(1):1-2. doi: 10.1211/jpp/61.01.0001.

Initial compound selection for sequential screening.

Curr Opin Drug Discov Devel. 2002 May;5(3):422-7.

The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy.

Curr Opin Investig Drugs. 2003 Jun;4(6):649-51.

引用本文的文献

Application of metal coordination chemistry to explore and manipulate cell biology.

Chem Rev. 2009 Oct;109(10):4921-60. doi: 10.1021/cr900134a.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.

Chem Biol Drug Des. 2006 Mar;67(3):196-200. doi: 10.1111/j.1747-0285.2006.00371.x.

The impact of systems approaches on biological problems in drug discovery.

Nat Biotechnol. 2004 Oct;22(10):1215-7. doi: 10.1038/nbt1004-1215.

Molecular targets and cancer therapeutics.

Drug Discov Today. 2004 Dec 15;9(24):1042-4. doi: 10.1016/S1359-6446(04)03287-8.

Can cell systems biology rescue drug discovery?

Nat Rev Drug Discov. 2005 Jun;4(6):461-7. doi: 10.1038/nrd1754.

Seeing is believing--visualizing drug delivery in vitro and in vivo.

Adv Drug Deliv Rev. 2005 Jun 15;57(8):1085-6. doi: 10.1016/j.addr.2005.01.019.

Ligand-based vascular targeting of disease.

ChemMedChem. 2007 Jan;2(1):22-40. doi: 10.1002/cmdc.200600181.

Value of novelty?

Nat Rev Drug Discov. 2002 Aug;1(8):571-2. doi: 10.1038/nrd884.

The journal of pharmacy and pharmacology 2008.

J Pharm Pharmacol. 2009 Jan;61(1):1-2. doi: 10.1211/jpp/61.01.0001.

Initial compound selection for sequential screening.

Curr Opin Drug Discov Devel. 2002 May;5(3):422-7.

The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy.

Curr Opin Investig Drugs. 2003 Jun;4(6):649-51.

引用本文的文献

Application of metal coordination chemistry to explore and manipulate cell biology.

Chem Rev. 2009 Oct;109(10):4921-60. doi: 10.1021/cr900134a.